nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study
|
Kyung, Yoon Soo |
|
|
17 |
5 |
p. e878-e884 |
artikel |
2 |
A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)
|
Shah, Ruchitbhai |
|
|
17 |
5 |
p. 356-365.e1 |
artikel |
3 |
Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy
|
Weprin, Samuel A. |
|
|
17 |
5 |
p. e1054-e1059 |
artikel |
4 |
Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis
|
Barata, Pedro C. |
|
|
17 |
5 |
p. 366-372 |
artikel |
5 |
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer
|
Knipper, Sophie |
|
|
17 |
5 |
p. 395-401 |
artikel |
6 |
Bladder Perivascular Epithelioid Cell Tumor: Dynamic CT and MRI Presentation of 2 Cases With 2-year Follow-up and Review of the Literature
|
Xuesong, Du |
|
|
17 |
5 |
p. e916-e922 |
artikel |
7 |
Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma
|
Maslov, Diana V. |
|
|
17 |
5 |
p. e913-e915 |
artikel |
8 |
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series
|
Casuscelli, Jozefina |
|
|
17 |
5 |
p. 373-379.e4 |
artikel |
9 |
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors
|
Verbiest, Annelies |
|
|
17 |
5 |
p. e981-e994 |
artikel |
10 |
Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis
|
Chen, Chenglong |
|
|
17 |
5 |
p. 319-331 |
artikel |
11 |
Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes
|
Su, Shiqiang |
|
|
17 |
5 |
p. e1048-e1053 |
artikel |
12 |
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer
|
Preisser, Felix |
|
|
17 |
5 |
p. e939-e945 |
artikel |
13 |
Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors
|
Palumbo, Carlotta |
|
|
17 |
5 |
p. e1026-e1035 |
artikel |
14 |
Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study
|
O’Reilly, David |
|
|
17 |
5 |
p. e886-e887 |
artikel |
15 |
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program
|
Saad, Fred |
|
|
17 |
5 |
p. 348-355.e5 |
artikel |
16 |
Editorial Board
|
|
|
|
17 |
5 |
p. A5 |
artikel |
17 |
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer
|
Fujiwara, Maki |
|
|
17 |
5 |
p. e923-e929 |
artikel |
18 |
Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non–Muscle-Invasive Bladder Cancer in Real-World Clinical Practice
|
Murakami, Kaoru |
|
|
17 |
5 |
p. e1003-e1010 |
artikel |
19 |
Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant
|
van Nuland, Merel |
|
|
17 |
5 |
p. e893-e896 |
artikel |
20 |
Folic Acid: A New Weapon for Mucositis?
|
Alkan, Ali |
|
|
17 |
5 |
p. e885 |
artikel |
21 |
Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology
|
Narayan, Vikram M. |
|
|
17 |
5 |
p. e888-e892 |
artikel |
22 |
High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy
|
Hapakova, Nikola |
|
|
17 |
5 |
p. e1020-e1025 |
artikel |
23 |
Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation
|
Beulque, Yana |
|
|
17 |
5 |
p. e909-e912 |
artikel |
24 |
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature
|
Vitale, Maria Giuseppa |
|
|
17 |
5 |
p. e903-e908 |
artikel |
25 |
Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy
|
Watanabe, Keitaro |
|
|
17 |
5 |
p. e897-e902 |
artikel |
26 |
Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program
|
Liao, Xinyang |
|
|
17 |
5 |
p. e968-e980 |
artikel |
27 |
Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index
|
De Nunzio, Cosimo |
|
|
17 |
5 |
p. 402-407 |
artikel |
28 |
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes
|
Di Nunno, Vincenzo |
|
|
17 |
5 |
p. e871-e877 |
artikel |
29 |
Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy
|
Huang, Haichao |
|
|
17 |
5 |
p. e1036-e1047 |
artikel |
30 |
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer
|
Stangl-Kremser, Judith |
|
|
17 |
5 |
p. 389-394 |
artikel |
31 |
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018
|
Marandino, Laura |
|
|
17 |
5 |
p. 332-347.e2 |
artikel |
32 |
Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry
|
Sung, John M. |
|
|
17 |
5 |
p. e995-e1002 |
artikel |
33 |
Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume
|
Omidele, Olamide O. |
|
|
17 |
5 |
p. e1011-e1019 |
artikel |
34 |
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study
|
Schmidinger, Manuela |
|
|
17 |
5 |
p. e957-e967 |
artikel |
35 |
Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study
|
Natale, Caleb |
|
|
17 |
5 |
p. 380-388 |
artikel |
36 |
Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing?
|
Tay, Kae Jack |
|
|
17 |
5 |
p. e930-e938 |
artikel |
37 |
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands
|
Westgeest, Hans M. |
|
|
17 |
5 |
p. e946-e956 |
artikel |
38 |
Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
|
Haque, Waqar |
|
|
17 |
5 |
p. e1069-e1079 |
artikel |
39 |
Table of Contents
|
|
|
|
17 |
5 |
p. A7-A13 |
artikel |
40 |
The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis
|
Sun, Yi |
|
|
17 |
5 |
p. e847-e859 |
artikel |
41 |
Transperineal Magnetic Resonance Imaging–Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis
|
Tu, Xiang |
|
|
17 |
5 |
p. e860-e870 |
artikel |
42 |
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study
|
Konishi, Sakae |
|
|
17 |
5 |
p. e1080-e1089 |
artikel |
43 |
Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer
|
Tan, Wei Shen |
|
|
17 |
5 |
p. e1060-e1068 |
artikel |